Markets:

Overview

News

Currencies

International

Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

84.68 -2.88 (-3.29%)

Streaming Delayed Price Updated: 12:07 PM EDT, Jun 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip ↗

March 28, 2024

Via Benzinga

Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations

March 28, 2024

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing

March 05, 2024

From Twist Bioscience Corporation

Via Business Wire

4 Analysts Have This To Say About Twist Bioscience ↗

February 05, 2024

Via Benzinga

Twist Bioscience Earnings Preview ↗

February 01, 2024

Via Benzinga

Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed ↗

February 26, 2024

On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ:

Via Benzinga

Twist Bioscience to Present at Upcoming Investor Conferences

February 22, 2024

From Twist Bioscience Corporation

Via Business Wire

Is The Stock Market Ready To Plunge? The Warning Signs Are Here... ↗

February 21, 2024

Find out how to spot the exhaustion of demand and the bearish analogue you could refer to to anticipate the down move.

Via Talk Markets

7 Stocks Cathie Wood Is Still Loading Up On in Q1 ↗

February 13, 2024

You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future.

Via InvestorPlace

7 Sexy Stocks That Will Continue to Outperform in 2024 ↗

February 11, 2024

These outperforming stocks are prime candidates for increasing in value sharply this year and beyond. Discover the top picks.

Via InvestorPlace

Cathie Wood Trims Nvidia, Shopify Stakes To Pump Whopping $40M Into Pinterest Despite Q4 Revenue Miss ↗

February 08, 2024

Via Benzinga

Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M ↗

February 07, 2024

Via Benzinga

Topics Artificial Intelligence

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

February 07, 2024

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System

February 06, 2024

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications

February 06, 2024

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT

February 05, 2024

From Twist Bioscience Corporation

Via Business Wire

Why Is DNA Synthesis Company Twist Bioscience Stock Trading Higher Today? ↗

February 02, 2024

Twist Bioscience reported Q1 2024 earnings, beating revenue guidance and increasing FY24 guidance. Shares are up 7.16%.

Via Benzinga

Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results

February 02, 2024

From Twist Bioscience Corporation

Via Business Wire

Earnings Scheduled For February 2, 2024 ↗

February 02, 2024

Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnings at $8.05 per share on revenue of $4.04 billion.

Via Benzinga

Twist Bioscience Corp Daily Investment Opportunity ↗

January 25, 2024

Twist Bioscience is a public biotechnology company founded in 2013 and it’s based in South San Francisco. It manufactures synthetic DNA and DNA products for customers in a wide range of industries.

Via Talk Markets

Twist Bioscience Expands Express Genes Rapid Synthesis Service

January 24, 2024

From Twist Bioscience Corporation

Via Business Wire

Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion ↗

January 17, 2024

Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing...

Via Benzinga

Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

January 17, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024

January 16, 2024

From Twist Bioscience Corporation

Via Business Wire

Biotech Playbook: Small Caps Show Momentum Peaking During ↗

January 15, 2024

The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market.

Via Talk Markets

Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

January 08, 2024

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Appoints Adam Laponis as Chief Financial Officer

January 05, 2024

From Twist Bioscience Corporation

Via Business Wire

3 Genomics Stocks to Unlock the Future of Medicine ↗

December 19, 2023

Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.

Via InvestorPlace

Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference

December 18, 2023

From Twist Bioscience Corporation

Via Business Wire

Tuesday Talk: CPI Data And FOMC Meeting Hold Back Market Breakout ↗

December 12, 2023

While the market continues towards making new highs, it is falling short of making a breakout rally. Forthcoming CPI data and the upcoming FOMC meeting may be the catalyst for same.

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.